Skip to content
10-K

Annual Report

PHARMACEUTICAL PRODUCT DEVELOPMENT INC

0001193125-11-046748

← back to feed
Filed
Feb 25, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2010 · Feb 15, 2011 115.2M sh
Shares Diluted FY 2010 · Dec 31, 2010 119.68M sh
Shares Diluted FY 2010 · Dec 31, 2009 118.77M sh
Shares Diluted FY 2010 · Dec 31, 2008 120.1M sh
Dividends Paid FY 2010 · Dec 31, 2010 $71.3M
Dividends Paid FY 2010 · Dec 31, 2009 $67.93M
Dividends Paid FY 2010 · Dec 31, 2008 $50.44M
Capex FY 2010 · Dec 31, 2010 $62.52M
Capex FY 2010 · Dec 31, 2009 $54.68M
Capex FY 2010 · Dec 31, 2008 $66.88M
Operating Cash Flow FY 2010 · Dec 31, 2010 $247.75M
Operating Cash Flow FY 2010 · Dec 31, 2009 $253M
Operating Cash Flow FY 2010 · Dec 31, 2008 $380.48M
Cash And Equivalents FY 2010 · Dec 31, 2010 $479.57M
Cash And Equivalents FY 2010 · Dec 31, 2009 $408.9M
Cash And Equivalents FY 2010 · Dec 31, 2008 $491.76M
Cash And Equivalents FY 2010 · Dec 31, 2007 $171.43M
Stockholders Equity FY 2010 · Dec 31, 2010 $1.28B
Stockholders Equity FY 2010 · Dec 31, 2009 $1.35B
Stockholders Equity FY 2010 · Dec 31, 2008 $1.18B
Current Liabilities FY 2010 · Dec 31, 2010 $613.71M
Current Liabilities FY 2010 · Dec 31, 2009 $591.04M
Total Liabilities FY 2010 · Dec 31, 2010 $701.38M
Total Liabilities FY 2010 · Dec 31, 2009 $684.08M
Current Assets FY 2010 · Dec 31, 2010 $1.13B
Current Assets FY 2010 · Dec 31, 2009 $1.13B
Total Assets FY 2010 · Dec 31, 2010 $1.99B
Total Assets FY 2010 · Dec 31, 2009 $2.03B
Eps Diluted FY 2010 · Dec 31, 2010 $1.04
Eps Diluted FY 2010 · Dec 31, 2009 $1.34
Eps Diluted FY 2010 · Dec 31, 2008 $1.56
Eps Basic FY 2010 · Dec 31, 2010 $1.05
Eps Basic FY 2010 · Dec 31, 2009 $1.35
Eps Basic FY 2010 · Dec 31, 2008 $1.58
Rd Expense FY 2010 · Dec 31, 2010 $16.73M
Rd Expense FY 2010 · Dec 31, 2009 $13.34M
Rd Expense FY 2010 · Dec 31, 2008 $7.62M
Net Income FY 2010 · Dec 31, 2010 $123.67M
Net Income FY 2010 · Dec 31, 2009 $159.3M
Net Income FY 2010 · Dec 31, 2008 $187.52M
Operating Income FY 2010 · Dec 31, 2010 $187.45M
Operating Income FY 2010 · Dec 31, 2009 $214.31M
Operating Income FY 2010 · Dec 31, 2008 $282.4M
Revenue FY 2010 · Dec 31, 2010 $1.47B
Revenue FY 2010 · Dec 31, 2009 $1.42B
Revenue FY 2010 · Dec 31, 2008 $1.55B
Stock Repurchased FY 2010 · Dec 31, 2008 $89.3M